PT74721A - Oxindol-derivate verfahren zu ihrer herstellung und sie enthaltende arzneimittel mit neuroanaboler wirkung - Google Patents
Oxindol-derivate verfahren zu ihrer herstellung und sie enthaltende arzneimittel mit neuroanaboler wirkungInfo
- Publication number
- PT74721A PT74721A PT74721A PT7472182A PT74721A PT 74721 A PT74721 A PT 74721A PT 74721 A PT74721 A PT 74721A PT 7472182 A PT7472182 A PT 7472182A PT 74721 A PT74721 A PT 74721A
- Authority
- PT
- Portugal
- Prior art keywords
- neuroanabolic
- production
- effect
- medicament containing
- derivatives method
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Psychiatry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Fats And Perfumes (AREA)
- Management, Administration, Business Operations System, And Electronic Commerce (AREA)
- Lubricants (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19813114351 DE3114351A1 (de) | 1981-04-09 | 1981-04-09 | "oxindol-derivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel mit neuroanaboler wirkung" |
Publications (2)
Publication Number | Publication Date |
---|---|
PT74721A true PT74721A (de) | 1982-05-01 |
PT74721B PT74721B (de) | 1984-05-30 |
Family
ID=6129772
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT74721A PT74721B (de) | 1981-04-09 | 1982-04-07 | Oxindol-derivate verfahren zu ihrer herstellung und sie enthaltende arzneimittel mit neuroanaboler wirkung |
Country Status (18)
Country | Link |
---|---|
US (2) | US4542148A (pt) |
EP (1) | EP0062887B1 (pt) |
JP (1) | JPS57179158A (pt) |
KR (1) | KR830010069A (pt) |
AT (1) | ATE8387T1 (pt) |
AU (1) | AU548411B2 (pt) |
DE (2) | DE3114351A1 (pt) |
DK (1) | DK162682A (pt) |
ES (2) | ES511097A0 (pt) |
FI (1) | FI821218L (pt) |
GR (1) | GR75450B (pt) |
HU (1) | HU186053B (pt) |
IL (1) | IL65466A0 (pt) |
NO (1) | NO821158L (pt) |
NZ (1) | NZ200259A (pt) |
PH (1) | PH19471A (pt) |
PT (1) | PT74721B (pt) |
ZA (1) | ZA822427B (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4619937A (en) * | 1984-02-02 | 1986-10-28 | Warner-Lambert Company | Saturated bicyclic lactam acids and derivatives as cognition activators |
DE3413572A1 (de) * | 1984-04-11 | 1985-10-24 | Hoechst Ag, 6230 Frankfurt | Oxindol-verbindungen zur behandlung der epilepsie |
US4686224A (en) * | 1984-10-31 | 1987-08-11 | Pfizer Inc. | Oxindole antiinflammatory agents |
DE3529994A1 (de) * | 1985-08-22 | 1987-02-26 | Hoechst Ag | Indolinonderivate, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung |
ES2110965T3 (es) * | 1989-07-25 | 1998-03-01 | Taiho Pharmaceutical Co Ltd | Derivado de oxoindol. |
SE514737C2 (sv) * | 1994-03-22 | 2001-04-09 | Sandvik Ab | Belagt skärverktyg av hårdmetall |
US5565483A (en) * | 1995-06-07 | 1996-10-15 | Bristol-Myers Squibb Company | 3-substituted oxindole derivatives as potassium channel modulators |
TW457233B (en) * | 1996-10-11 | 2001-10-01 | Bristol Myers Squibb Co | Preparation of 3-fluoro oxindole derivatives |
US7790726B2 (en) * | 2005-08-16 | 2010-09-07 | Chemocentryx, Inc. | Monocyclic and bicyclic compounds and methods of use |
AU2007279092B2 (en) * | 2006-07-24 | 2012-12-13 | Ucb Pharma S.A. | Substituted aniline derivatives |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3573310A (en) * | 1967-09-28 | 1971-03-30 | Miles Lab | 1-substituted derivatives of 2-indolinone |
US3558653A (en) * | 1968-05-20 | 1971-01-26 | Searle & Co | Dialkylaminoalkyl-indolines |
JPS4876863A (pt) * | 1972-01-22 | 1973-10-16 | ||
US3975531A (en) * | 1973-10-02 | 1976-08-17 | A. H. Robins Company, Incorporated | 4-(5- And 7-)benzoylindolin-2-ones and pharmaceutical uses thereof |
US4080330A (en) * | 1975-06-23 | 1978-03-21 | Delmar Chemicals Limited | Phenylindolines and process for their production |
US4110465A (en) * | 1977-11-25 | 1978-08-29 | Eli Lilly And Company | 7-amino and 7-alkanoylamino 2-oxo-3-phenylindolines |
-
1981
- 1981-04-09 DE DE19813114351 patent/DE3114351A1/de not_active Withdrawn
-
1982
- 1982-04-02 ES ES511097D patent/ES511097A0/es active Granted
- 1982-04-06 AT AT82102936T patent/ATE8387T1/de active
- 1982-04-06 NO NO821158A patent/NO821158L/no unknown
- 1982-04-06 EP EP82102936A patent/EP0062887B1/de not_active Expired
- 1982-04-06 DE DE8282102936T patent/DE3260356D1/de not_active Expired
- 1982-04-06 FI FI821218A patent/FI821218L/fi not_active Application Discontinuation
- 1982-04-07 GR GR67851A patent/GR75450B/el unknown
- 1982-04-07 PH PH27110A patent/PH19471A/en unknown
- 1982-04-07 US US06/366,321 patent/US4542148A/en not_active Expired - Fee Related
- 1982-04-07 KR KR1019820001528A patent/KR830010069A/ko unknown
- 1982-04-07 PT PT74721A patent/PT74721B/pt unknown
- 1982-04-07 NZ NZ200259A patent/NZ200259A/en unknown
- 1982-04-07 DK DK162682A patent/DK162682A/da not_active IP Right Cessation
- 1982-04-08 AU AU82487/82A patent/AU548411B2/en not_active Ceased
- 1982-04-08 HU HU821080A patent/HU186053B/hu unknown
- 1982-04-08 ZA ZA822427A patent/ZA822427B/xx unknown
- 1982-04-08 JP JP57057411A patent/JPS57179158A/ja active Pending
- 1982-04-11 IL IL65466A patent/IL65466A0/xx unknown
-
1983
- 1983-03-30 ES ES521198A patent/ES521198A0/es active Granted
-
1985
- 1985-06-18 US US06/745,884 patent/US4614739A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0062887B1 (de) | 1984-07-11 |
GR75450B (pt) | 1984-07-19 |
ATE8387T1 (de) | 1984-07-15 |
ES8401940A1 (es) | 1984-01-01 |
HU186053B (en) | 1985-05-28 |
US4614739A (en) | 1986-09-30 |
ES8307217A1 (es) | 1983-06-16 |
ES521198A0 (es) | 1984-01-01 |
US4542148A (en) | 1985-09-17 |
FI821218L (fi) | 1982-10-10 |
PT74721B (de) | 1984-05-30 |
JPS57179158A (en) | 1982-11-04 |
AU548411B2 (en) | 1985-12-12 |
DE3114351A1 (de) | 1982-11-04 |
PH19471A (en) | 1986-05-14 |
AU8248782A (en) | 1983-04-21 |
KR830010069A (ko) | 1983-12-26 |
FI821218A0 (fi) | 1982-04-06 |
NZ200259A (en) | 1985-07-31 |
ZA822427B (en) | 1983-02-23 |
ES511097A0 (es) | 1983-06-16 |
DE3260356D1 (en) | 1984-08-16 |
DK162682A (da) | 1982-10-10 |
IL65466A0 (en) | 1982-07-30 |
NO821158L (no) | 1982-10-11 |
EP0062887A1 (de) | 1982-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE6859T1 (de) | Substituierte 3-amino-sydnonimine, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate. | |
ATE27451T1 (de) | Acyl-chinolinonderivate, verfahren zu ihrer herstellung, diese enthaltende pharmazeutische praeparate und ihre verwendung. | |
ATE4707T1 (de) | Pyridyl- und imidazopyridyloxypropanolamine, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen sie enthaltend. | |
PT74721A (de) | Oxindol-derivate verfahren zu ihrer herstellung und sie enthaltende arzneimittel mit neuroanaboler wirkung | |
ATE10634T1 (de) | Pyrazoloindazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitung. | |
ATE9330T1 (de) | Phenethanolamin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
ATE14309T1 (de) | Pyrazolinderivate, verfahren zu ihrer herstellung und diese enthaltende insektizide praeparate. | |
ATE55129T1 (de) | Pyrazol-derivate mit einem ergolingeruest, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
ATE37548T1 (de) | Thiazaspiranderivate, verfahren zu ihrer herstellung und arzneimittel. | |
DE3481418D1 (de) | Substituierte spiropyridinderivate, diese enthaltende pharmazeutische zubereitungen, verfahren zu ihrer herstellung und zubereitungen. | |
ATE3422T1 (de) | Tetrahydrochinolinderivate, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende pharmazeutische zubereitungen. | |
ATE26577T1 (de) | 1-0-alkyl-3-amino-propan-1.2-diol-2-0phospholipide, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten. | |
ATE3976T1 (de) | Substituierte 3-(1-pyrrolidinyl)-5-sulfamoylbenzoes[ure-derivate, verfahren zu ihrer herstellung, pharmazeutische zubereitungen, die sie enthalten und verfahren zu deren herstellung. | |
LU84492A1 (de) | Cumarin-derivate,verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische praeparate | |
ATE722T1 (de) | Octahydro-1h-benzo(4,5)fu ro(3,2-e)isochinolinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
ATE6503T1 (de) | Carboxyalkyl-dipeptid-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzung. | |
ATE11290T1 (de) | Cephalosporinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
ATE7143T1 (de) | Cephalosporinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
ATE4986T1 (de) | Cephalosporinderivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten. | |
ATE12116T1 (de) | 7-acylamino-3-substituierte cephalasporansaeurederivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
ATE6653T1 (de) | Clavulansaeurederivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
ATE2673T1 (de) | Phenothiazinderivate, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung. | |
ATE7599T1 (de) | 1,2,4-triazol-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
ATE7140T1 (de) | 1,2,4-triazol-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
ATE21515T1 (de) | 7-n-heterocyclyl-cephalosporinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzung. |